Dr. Rabin’s research has two primary directions. As the neuropsychology lead in the Harquail Centre for Neuromodulation, her research characterizes cognitive and behavioural changes associated with novel neuromodulation strategies. This includes low-intensity focused ultrasound (FUS) to open up the blood-brain barrier in patients with Alzheimer’s disease, and high-intensity FUS to treat severe psychiatric and neurological conditions, like depression, obsessive-compulsive disorder and tremor.